Strep Throat Treatment - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240750

Publication Date:

September 5, 2024

Pages:

114

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Penicillin or amoxicillin is the antibiotic of choice to treat group A strep pharyngitis. There has never been a report of a clinical isolate of group A strep that is resistant to penicillin. However, resistance to azithromycin and clarithromycin is common in some communities.
The global market for Strep Throat Treatment was estimated to be worth US$ 1986 million in 2023 and is forecast to a readjusted size of US$ 2698.4 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030
The strep throat treatment drugs market is driven by the prevalence of streptococcal infections and the need for effective treatment options. Strep throat is a common bacterial infection caused by Streptococcus bacteria, affecting millions of people worldwide. The rise in the incidence of strep throat and its potential complications, such as rheumatic fever and kidney damage, contribute to market growth. The market is propelled by the development of new and improved antibiotics and other therapeutics targeting streptococcal infections. However, the market also faces challenges, including antibiotic resistance, which poses a threat to treatment efficacy. Additionally, the difficulty in distinguishing between strep throat and viral infections, as well as the overuse of antibiotics, can pose obstacles for accurate diagnosis and appropriate treatment selection. To succeed, companies must focus on research and development to combat antibiotic resistance, collaborate with healthcare providers to improve diagnostic accuracy, and work towards providing targeted and effective strep throat treatment drugs to meet the increasing demand for effective therapeutic options.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Strep Throat Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Strep Throat Treatment by region & country, by Type, and by Application.
The Strep Throat Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Strep Throat Treatment.
麻豆原创 Segmentation
By Company
Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health
Segment by Type:
Penicillin
Amoxicillin
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Strep Throat Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Strep Throat Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Strep Throat Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Strep Throat Treatment Product Introduction
1.2 Global Strep Throat Treatment 麻豆原创 Size Forecast
1.3 Strep Throat Treatment 麻豆原创 Trends & Drivers
1.3.1 Strep Throat Treatment Industry Trends
1.3.2 Strep Throat Treatment 麻豆原创 Drivers & Opportunity
1.3.3 Strep Throat Treatment 麻豆原创 Challenges
1.3.4 Strep Throat Treatment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Strep Throat Treatment Players Revenue Ranking (2023)
2.2 Global Strep Throat Treatment Revenue by Company (2019-2024)
2.3 Key Companies Strep Throat Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Strep Throat Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Strep Throat Treatment
2.6 Strep Throat Treatment 麻豆原创 Competitive Analysis
2.6.1 Strep Throat Treatment 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Strep Throat Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Strep Throat Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Penicillin
3.1.2 Amoxicillin
3.2 Global Strep Throat Treatment Sales Value by Type
3.2.1 Global Strep Throat Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Strep Throat Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Strep Throat Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Diagnostic Laboratories
4.2 Global Strep Throat Treatment Sales Value by Application
4.2.1 Global Strep Throat Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Strep Throat Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Strep Throat Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Strep Throat Treatment Sales Value by Region
5.1.1 Global Strep Throat Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Strep Throat Treatment Sales Value by Region (2019-2024)
5.1.3 Global Strep Throat Treatment Sales Value by Region (2025-2030)
5.1.4 Global Strep Throat Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Strep Throat Treatment Sales Value, 2019-2030
5.2.2 North America Strep Throat Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Strep Throat Treatment Sales Value, 2019-2030
5.3.2 Europe Strep Throat Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Strep Throat Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Strep Throat Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Strep Throat Treatment Sales Value, 2019-2030
5.5.2 South America Strep Throat Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Strep Throat Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Strep Throat Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Strep Throat Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Strep Throat Treatment Sales Value
6.3 United States
6.3.1 United States Strep Throat Treatment Sales Value, 2019-2030
6.3.2 United States Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Strep Throat Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Strep Throat Treatment Sales Value, 2019-2030
6.4.2 Europe Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Strep Throat Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Strep Throat Treatment Sales Value, 2019-2030
6.5.2 China Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Strep Throat Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Strep Throat Treatment Sales Value, 2019-2030
6.6.2 Japan Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Strep Throat Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Strep Throat Treatment Sales Value, 2019-2030
6.7.2 South Korea Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Strep Throat Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Strep Throat Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Strep Throat Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Strep Throat Treatment Sales Value, 2019-2030
6.9.2 India Strep Throat Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Strep Throat Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck & co.
7.1.1 Merck & co. Profile
7.1.2 Merck & co. Main Business
7.1.3 Merck & co. Strep Throat Treatment Products, Services and Solutions
7.1.4 Merck & co. Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Merck & co. Recent Developments
7.2 Pfizer
7.2.1 Pfizer Profile
7.2.2 Pfizer Main Business
7.2.3 Pfizer Strep Throat Treatment Products, Services and Solutions
7.2.4 Pfizer Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Pfizer Recent Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Profile
7.3.2 Abbott Laboratories Main Business
7.3.3 Abbott Laboratories Strep Throat Treatment Products, Services and Solutions
7.3.4 Abbott Laboratories Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Strep Throat Treatment Products, Services and Solutions
7.4.4 Johnson & Johnson Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Strep Throat Treatment Products, Services and Solutions
7.5.4 Roche Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Strep Throat Treatment Products, Services and Solutions
7.6.4 Novartis Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Profile
7.7.2 Bristol-Myers Squibb Main Business
7.7.3 Bristol-Myers Squibb Strep Throat Treatment Products, Services and Solutions
7.7.4 Bristol-Myers Squibb Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Bristol-Myers Squibb Recent Developments
7.8 Eli Lily
7.8.1 Eli Lily Profile
7.8.2 Eli Lily Main Business
7.8.3 Eli Lily Strep Throat Treatment Products, Services and Solutions
7.8.4 Eli Lily Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Eli Lily Recent Developments
7.9 Astra Zeneca
7.9.1 Astra Zeneca Profile
7.9.2 Astra Zeneca Main Business
7.9.3 Astra Zeneca Strep Throat Treatment Products, Services and Solutions
7.9.4 Astra Zeneca Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Astra Zeneca Recent Developments
7.10 Bayer
7.10.1 Bayer Profile
7.10.2 Bayer Main Business
7.10.3 Bayer Strep Throat Treatment Products, Services and Solutions
7.10.4 Bayer Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Bayer Recent Developments
7.11 Bausch Health
7.11.1 Bausch Health Profile
7.11.2 Bausch Health Main Business
7.11.3 Bausch Health Strep Throat Treatment Products, Services and Solutions
7.11.4 Bausch Health Strep Throat Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Bausch Health Recent Developments
8 Industry Chain Analysis
8.1 Strep Throat Treatment Industrial Chain
8.2 Strep Throat Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Strep Throat Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Strep Throat Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.